An international research team co-led by scientists at Roswell Park Comprehensive Cancer Center and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has identified an important accelerator of treatment-resistant prostate cancer. The study, published Tuesday in Cell Reports, provides insight into how loss or mutation of the NCOR2 gene accelerates the progression of prostate cancer to a more lethal form of the disease.

Roswell Park Comprehensive Cancer Center held a ceremonial groundbreaking Monday for the Roswell Park Scott Bieler Amherst Center, an expanded Amherst location on Park Club Lane. The new center will be Roswell Park’s first new-build outside of its downtown Buffalo campus. Announced in August 2021, the new center will be named for longtime supporter Scott Bieler in recognition of a significant gift made to the Roswell Park Alliance Foundation.

Roswell Park hematology experts in leukemia, lymphoma and other specialties will present new research at the 63rd annual meeting of the American Society of Hematology (ASH) in Atlanta, Georgia.

Roswell Park Comprehensive Cancer Center is one of three lead centers part of an international multicenter team that has recently been awarded $10 million to study how tobacco control policies impact smoking, vaping and the use of other nicotine products.